These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


490 related items for PubMed ID: 17592368

  • 1. Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection.
    Fischler B, Nyström J, Björnsdottir T, Lindh G, Hultgren C.
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):75-83. PubMed ID: 17592368
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA, Quiroga JA, Subirá D, Castañón S, Esteban JM, Pardo M, Carreño V.
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1840-3. PubMed ID: 17922996
    [Abstract] [Full Text] [Related]

  • 6. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion.
    Ni YH, Chang MH, Chen PJ, Tsai KS, Hsu HY, Chen HL, Tsuei DJ, Chen DS.
    Gastroenterology; 2007 Jun 10; 132(7):2340-5. PubMed ID: 17570209
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL.
    Hepatology; 2001 Jul 10; 34(1):139-45. PubMed ID: 11431745
    [Abstract] [Full Text] [Related]

  • 8. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H, Ma LX, Xu WS, Zhang HY, Yu LJ, Duan HY.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar 10; 11(3):173-5. PubMed ID: 12681068
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC, Yulugkural Z, Vahaboglu H.
    Chemotherapy; 2007 Mar 10; 53(6):402-6. PubMed ID: 17934260
    [Abstract] [Full Text] [Related]

  • 11. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region.
    Maruyama T, Mitsui H, Maekawa H, Yamada H, Hirayama M, Iino S, Yasuda K, Koike K, Kimura S, Milich DR.
    Am J Gastroenterol; 2000 Oct 10; 95(10):2894-904. PubMed ID: 11051365
    [Abstract] [Full Text] [Related]

  • 12. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
    Krastev Z, Jelev D, Antonov K, Alagozian V, Kotzev I.
    Hepatogastroenterology; 1999 Oct 10; 46(30):3184-8. PubMed ID: 10626183
    [Abstract] [Full Text] [Related]

  • 13. Effect of puberty onset on spontaneous hepatitis B virus e antigen seroconversion in men.
    Wu JF, Tsai WY, Hsu HY, Ni YH, Chen HL, Tsuei DJ, Chang MH.
    Gastroenterology; 2010 Mar 10; 138(3):942-8.e1. PubMed ID: 19962986
    [Abstract] [Full Text] [Related]

  • 14. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
    Bozkaya H, Bozdayi M, Türkyilmaz R, Sarioglu M, Cetinkaya H, Cinar K, Köse K, Yurdaydin C, Uzunalimoglu O.
    Hepatogastroenterology; 2000 Mar 10; 47(36):1675-9. PubMed ID: 11149030
    [Abstract] [Full Text] [Related]

  • 15. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    Gastroenterology; 2009 Feb 10; 136(2):505-12. PubMed ID: 19101558
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationship between viral load and genotypes of hepatitis B virus in children with chronic hepatitis B.
    Oommen PT, Wirth S, Wintermeyer P, Gerner P.
    J Pediatr Gastroenterol Nutr; 2006 Sep 10; 43(3):342-7. PubMed ID: 16954957
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients.
    Lian M, Zhou X, Wei L, Qiu S, Zhou T, Li L, Gu X, Luo M, Zheng X.
    Virol J; 2007 Sep 24; 4():93. PubMed ID: 17892580
    [Abstract] [Full Text] [Related]

  • 19. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
    van der Eijk AA, Niesters HG, Hansen BE, Heijtink RA, Janssen HL, Schalm SW, de Man RA.
    J Viral Hepat; 2006 Feb 24; 13(2):96-103. PubMed ID: 16436127
    [Abstract] [Full Text] [Related]

  • 20. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH, Song BC, Lee GC, Shin JW, Ryu SH, Jung SA, Yoo K, Lee HC, Lee YS, Suh DJ.
    Eur J Gastroenterol Hepatol; 2003 May 24; 15(5):489-93. PubMed ID: 12702905
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.